These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37543291)

  • 1. New liposome-radionuclide-chelate combination for tumor targeting and rapid healthy tissue clearance.
    Umeda IO; Koike Y; Ogata M; Kaneko E; Hamamichi S; Uehara T; Moribe K; Arano Y; Takahashi T; Fujii H
    J Control Release; 2023 Sep; 361():847-855. PubMed ID: 37543291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a liposome-encapsulated radionuclide with preferential tumor accumulation--the choice of radionuclide and chelating ligand.
    Ogihara-Umeda I; Sasaki T; Nishigori H
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):753-7. PubMed ID: 1399696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals.
    Kostarelos K; Emfietzoglou D
    Anticancer Res; 2000; 20(5A):3339-45. PubMed ID: 11062762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal radiolabeled liposomes for tumor imaging.
    Ogihara-Umeda I; Sasaki T; Kojima S; Nishigori H
    J Nucl Med; 1996 Feb; 37(2):326-32. PubMed ID: 8667071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
    Emfietzoglou D; Kostarelos K; Sgouros G
    J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.
    Hrycushko BA; Li S; Goins B; Otto RA; Bao A
    Med Phys; 2011 Mar; 38(3):1339-47. PubMed ID: 21520844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics.
    Llop J; Lammers T
    ACS Nano; 2021 Nov; 15(11):16974-16981. PubMed ID: 34748314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use and importance of liposomes in positron emission tomography.
    Silindir M; Özer AY; Erdoğan S
    Drug Deliv; 2012 Jan; 19(1):68-80. PubMed ID: 22211758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
    Bao A; Goins B; Klipper R; Negrete G; Phillips WT
    J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 64Cu loaded liposomes as positron emission tomography imaging agents.
    Petersen AL; Binderup T; Rasmussen P; Henriksen JR; Elema DR; Kjær A; Andresen TL
    Biomaterials; 2011 Mar; 32(9):2334-41. PubMed ID: 21216003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel liposome radiolabeling method using 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation.
    Bao A; Goins B; Klipper R; Negrete G; Mahindaratne M; Phillips WT
    J Pharm Sci; 2003 Sep; 92(9):1893-904. PubMed ID: 12950007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors.
    Ogihara-Umeda I; Kojima S
    Eur J Nucl Med; 1989; 15(9):612-7. PubMed ID: 2598958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
    Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density.
    Gray BP; McGuire MJ; Brown KC
    PLoS One; 2013; 8(8):e72938. PubMed ID: 24009717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft.
    Li S; Goins B; Phillips WT; Saenz M; Otto PM; Bao A
    Breast Cancer Res Treat; 2011 Nov; 130(1):97-107. PubMed ID: 21181436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.
    Lin LT; Chang CH; Yu HL; Liu RS; Wang HE; Chiu SJ; Chen FD; Lee TW; Lee YJ
    J Nucl Med; 2014 Nov; 55(11):1864-70. PubMed ID: 25349220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Molecular Imaging of the Enhanced Permeability and Retention Effect by
    Børresen B; Hansen AE; Fliedner FP; Henriksen JR; Elema DR; Brandt-Larsen M; Kristensen LK; Kristensen AT; Andresen TL; Kjær A
    Int J Nanomedicine; 2020; 15():8571-8581. PubMed ID: 33173294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
    Krishna R; Mayer LD
    Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.